EUVIMEDEUVIMED entdecken
VergleichsstudieRandomisierte kontrollierte Studie

The pharmacokinetics and comparative bioavailabilty of oral and subcutaneous semaglutide in healthy volunteers

Mohammed Bouhajib, Zia Tayab iD, Chantal Di Marco, Dennis Dong-Kyun Suh

Journal of Basic and Clinical Physiology and Pharmacology · 2025

DOI: 10.1515/jbcpp-2025-0026 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Basic and Clinical Physiology and Pharmacology, 2025. Verfasst von Mohammed Bouhajib und 3 weiteren Autor:innen. Beteiligte Einrichtung: 352314 Pharma Medica Research Inc , Mississauga, ON, Canada. Hauptthemen laut MEDLINE: Glucagon-Like Peptides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

In this study, the comparative bioavailability of semaglutide following the administration of oral (PO) and subcutaneous (SC) doses in healthy subjects was evaluated. The pharmacokinetics of semaglutide of these formulations at lower doses (SC dose of 0.25 mg; PO dose of 3 mg) was examined by utilizing a sensitive bioanalytical method.

Methods

Twenty-two subjects were administered either 0.25 mg SC or 3 mg PO and blood samples were taken up to 504 h. The samples were assayed for semaglutide with an analytical range of 0.05–50 ng/mL. The pharmacokinetic parameters were estimated using a non-compartmental approach and were used to evaluate the comparative bioavailability of semaglutide.

Results

The pharmacokinetics of semaglutide was characterized following the administration of low subcutaneous and oral doses. The comparative bioavailability (PO relative to SC) was 0.66 % at the doses administered. Overall, the study drug was well tolerated, and no serious adverse events were reported.

Conclusions

The bioavailability of semaglutide following oral and subcutaneous administrations has been determined using a validated bioanalytical method. This method will enable more investigations into the pharmacokinetics of all formulations of semaglutide at lower doses, which will enable a better understanding of its’ disposition in healthy subjects and in patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like PeptidesHumansBiological AvailabilityAdministration, OralInjections, SubcutaneousAdultMaleHealthy VolunteersFemaleYoung AdultMiddle AgedGlucagon-Like Peptide 1Semaglutide

Stichwörter der Autor:innen

bioanalytical methodbioavailablitypharmcokineticssubcutaneous

Substanzen

Glucagon-Like PeptidesGlucagon-Like Peptide 1Semaglutide

Autor:innen und Institutionen

  • 352314 Pharma Medica Research Inc , Mississauga, ON, Canada.

ORCID-Profile: Zia Tayab

Zitieren

APA

Bouhajib, M., Tayab, Z., Di Marco, C., & Suh, D. D. (2025). The pharmacokinetics and comparative bioavailabilty of oral and subcutaneous semaglutide in healthy volunteers. Journal of Basic and Clinical Physiology and Pharmacology. https://doi.org/10.1515/jbcpp-2025-0026

Vancouver

Bouhajib M, Tayab Z, Di Marco C, Suh DD. The pharmacokinetics and comparative bioavailabilty of oral and subcutaneous semaglutide in healthy volunteers. Journal of Basic and Clinical Physiology and Pharmacology. 2025. doi:10.1515/jbcpp-2025-0026

BibTeX
@article{Bouhajib2025,
  author = {Bouhajib, Mohammed and Tayab, Zia and Di Marco, Chantal and Suh, Dennis Dong-Kyun},
  title = {The pharmacokinetics and comparative bioavailabilty of oral and subcutaneous semaglutide in healthy volunteers},
  journal = {Journal of Basic and Clinical Physiology and Pharmacology},
  year = {2025},
  doi = {10.1515/jbcpp-2025-0026}
}
Kostenlos starten →